This review highlights the central role of protein quality control derailment in the pathogenesis of inherited cardiomyopathies and discusses potential therapeutic applications targeting proteostasis.
No takes yet. Share an insight, caveat, or question.
Supports proteostasis-targeted therapies in inherited cardiomyopathies; leaves open confirmation in prospective trials.
Dorsch et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: